Abstract. A total of 234 patients with neuropathic bladder dysfunction and bacteria in the urine have been studied for the presence of antibody coating on the bacteria. Approxi mately one third of the patients so studied were found to have antibody coated bacteria in the urine (ACB+) by fluorescent microscopy. No correlation could be found between evidence of active tissue infection by the ACB test and the age, sex or catheter status of the patient, the radiological findings or the length of time since the neurological injury. There did, however, appear to be significant differences among the bacterial species isolated, in their ability to invade through urothelium. Testing for antibody coating is a useful epidemiological tool, but is not indicated for routine use as a guide to therapy. The choice of antibacterial drugs can, in most instances, be based on the identification of the bacterial isolate and its known potential for invasion of the upper urinary tract.
Introduction
A SIMPLE, non-invasive technique claimed to detect active infection of the upper urinary tract was described by Thomas, Shelokov & Forland in 1974 . Based on the findings of Pearsall & Sherris (1966) that bacteria reaching the kidney stimulate the production of antibody to the bacterial O-antigen, they applied fluorescein tagged antihuman-globulin antibody to washed bacteria in freshly obtained urine sediments. Any bacteria which have been coated with antibody globulin will, by this technique, appear as fluorescent when viewed under a V.V.-light microscope. Jones, Smith & Sanford (1974) reported finding a high degree of correlation between antibody coating and infected ureteral specimens of urine, indicating that antibody coating of bacteria occurs in the kidney.
Since 1974, we have studied 234 patients with neuropathic bladder dysfunction with the object of determining the incidence of antibody coated bacteria in their urines, firstly as it relates to other evidence of renal infection and secondly as it relates to the types of bacteria isolated.
Method
The method we used was that of Thomas and her associates. Wet sediments were examined under both dark field and V.V. illumination, using fluorescein tagged horse-antihuman globulin (Roboz) or goat-antihuman globulin (Miles Laboratories). 'Blocking' antibody (Difco), cultured isolates and urine sediments from proven cases of pyelonephritis were used as controls.
All urine specimens were obtained by bladder catheterisation. Following the aseptic insertion of a sterile urethral catheter the bladder was rinsed three times with 50 ml of sterile saline and the catheter was then clamped for 30 minutes before obtaining the specimen. This precaution is necessary in order to avoid contami nation from organisms residing in the prostate or urethral canal which, it has been shown, may also acquire antibody coating (Jones, 1974) .
Study group
Among the patients studied were 193 men and 41 women ranging in age from the teens to the 70S during the study period, with an average age of 20-30 years. Their injuries dated from as recently as 2 months to as long as 14 years before, with an average of 4 years. All the patients had had indwelling Foley catheters at one time (and 70 still used them), while 164 had become catheter-free at the time of the study.
There were IIO paraplegics and 103 tetraplegics with complete lesions and 21 patients with other neurological lesions (central cord syndromes, transverse myelitis and incomplete cord transections).
None of the patients was receiving therapeutic antibacterials at the time the urine specimens were obtained. The majority were on a permanent regimen of urinary acidifiers and urinary antiseptics in suppressive doses, aimed at preventing bacterial multiplication in the bladder but had not received any of these agents for the 12 hours preceding the test.
Results and Discussion
In 34 per cent, or one third of the 234 patients, the urine specimens obtained were found to be positive for antibody coated bacteria (ACB + ).
No correlation could be found between this evidence of active tissue infection and the age, sex or catheter status of the patients, nor the length of time since the cord injury.
The relationship between radiological evidence of upper tract disease and antibody coating of bacteria is shown in Table I . When the radiological picture was negative, the majority of cases were also negative for antibody coated bacteria in the urine, but a minority of more than 20 per cent were positive. On the other hand when the X-rays did show evidence of calyceal blunting we found that over 70 per cent of these patients had urine with bacteria which were negative for antibody coating. Thus, assuming that antibody coating indicates active upper tract infection, it would appear that IVP appearances are a rather poor guide to the presence or absence of active kidney infections. We did find a very significant correlation between the genus of the bacterial isolates and their ability as judged by this test, to invade the tissues of the urinary tract. They appeared to fall quite clearly into three groups (Table II) . On the assumption that antibody coated bacteria, detected by this method, denote the presence of active upper urinary tract infection, we can advance the hypothesis that 50 per cent of our patients with E. coli and proteus infections have upper tract ISS involvement. Among klebsiella or enterobacter strains the great majority were ACB +, indicating that these organisms probably have the highest virulence in this type of patient and that such infections should therefore be treated promptly and vigorously. By contrast, the classically opportunist organisms such as pseudomonas, serratia, providencia stuartii or citrobacter were practically never antibody coated, even on retesting over periods of 6 months to 2 years of continuous carriage. These organisms are all highly resistant to the more common anti bacterials but, on the basis of our findings, it would seem that the isolation of such organisms from the urines of patients with a neuropathic bladder does not necessarily, nor usually, warrant therapy with toxic or expensive antibiotic drugs.
Summary
The testing of urine sediments from patients with neurogenic bladder dys function for the presence of antibody coated bacteria is an important tool in epidemiological studies, since it appears to be a more sensitive indicator of early renal infection than radiological studies. It is a time-consuming test and it is probably not necessary to perform it in every individual case as a guide to treatment. The advisability of selecting antibacterial drugs which are active in renal tissue can probably be better deduced in this type of patient from the species of the infecting bacteria.
RESUME
Deux cents trente quatre patients atteints d'une dysfonction neurologique de la vessie urinaire et dont l'urine contenait les bacteries, ont etudie pour la presence d'une couche anticorps sur les bacteries (ACB).
La microscopie fluorescente a revele une couche d'anticorps bacteriens dans environs un tiers des cas etudies. On n'a pas trouve de correlation entre l'infection active des tissus, mise en evidence en testant la presence d' ACB, et l'iige ou Ie sexe du patient, 1a presence ou absence de catheter, les constations radiologiques ou Ie lapse de temps ecoule depuis la lesion neurologique. Cependant, les tests ont montre des differences importantes entre les types de bacteries isoles dans leur capacite de penetrer l'epithelium urinaire.
Les ACB tests sont un util epidemiologique utile, mais ne sont pas recommendes en tant qu'indicer pour Ie traitement. Le choix des bactericides devrait etre fonde sur l'identifi cation de l'isolant bacterien et sur son potentiel de penetration de la voie urinaire superieur. 
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